Salticin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Salticin

What is Salticin? Defining the Aminoglycoside Antibiotic

Property Description
Active ingredient Gentamicin Sulfate
Form Solution (Injection), Ointment, Eye Drops
Pharmacological class Aminoglycoside Antibiotic
Common purpose Eradicating Bacterial Infections
Origin Natural (Fermentation product)

Salticin is a prescription-only medication whose active component is Gentamicin Sulfate, fundamentally classifying it as a potent aminoglycoside antibiotic. Its primary purpose is to act as a powerful bactericidal agent, working to actively destroy harmful bacteria responsible for infections.

The drug belongs to the comprehensive aminoglycoside antibacterial class, which is clinically recognized for its broad-spectrum effectiveness, particularly against various Gram-negative bacteria. This class of drugs is used in treating serious systemic infections due to its rapid bactericidal effect. The medication is designed for decisive action in eliminating bacterial threats.


Composition, Origin, and Available Forms

The active ingredient in Salticin, Gentamicin, is a sulfate salt that is naturally derived as a fermentation product from the soil bacterium, Micromonospora purpurea. This natural origin distinguishes it from purely synthetic antibacterials.

Chemically, the medication is a complex mixture whose active entities comprise the Gentamicin C complex. This formulation flexibility is a key feature, enabling the drug to be available for diverse applications: it is prepared as a Sterile Solution for parenteral (injection) use to treat systemic concerns, and also as an Ophthalmic Solution (eye drops), Ophthalmic Ointment, and a Topical Ointment for localized surface treatment. These various formulations include use in ophthalmic solutions for surface eye infections.

General Purpose

The general purpose of Gentamicin Sulfate is to provide a highly effective means of eradicating bacterial infections by targeting the pathogens' fundamental life processes. This function is achieved by interrupting the bacteria's ability to create necessary proteins, swiftly resolving the underlying threat.

Regulatory References

  1. National Library of Medicine (NLM)
  2. NLM Review on Aminoglycosides

What side effects are possible with Salticin?

Possible Side Effects and Safety Information

The officially documented safety profile for Salticin (Gentamicin Sulfate), an aminoglycoside antibiotic, centers on potential toxicity to key physiological systems, as classified by government regulatory agencies.


Key Adverse Reaction Categories

The two principal adverse reaction categories documented in official labeling are Nephrotoxicity (damage to the kidneys) and Ototoxicity (damage to the inner ear, affecting both hearing and balance). These effects are categorized by frequency:

  • Common (may affect up to 1 in 10 people): Nephrotoxicity, often indicated by an increase in blood creatinine levels, which is frequently noted as being reversible upon cessation of the medicine.
  • Uncommon (may affect up to 1 in 100 people): Vestibular Ototoxicity (balance disturbance) and gastrointestinal effects like nausea and vomiting.
  • Rare (may affect up to 1 in 1,000 people): Cochlear Ototoxicity potentially leading to permanent bilateral hearing loss, as well as Neuromuscular Blockade.

Serious Reactions and Safety Considerations

Regulatory sources explicitly list Permanent Hearing Loss and Acute Renal Failure as serious adverse reactions. The medicine is contraindicated in individuals with a known history of hypersensitivity to gentamicin or other aminoglycosides.

Safety notes specify that the risk of both Nephrotoxicity and Ototoxicity is officially documented as increased by two key factors: prolonged treatment duration and the presence of impaired renal function. For this reason, special considerations apply to older adults and those with pre-existing kidney issues.


Regulatory Summary

The safety profile is structured to emphasize organ-specific toxicity and risk factors. The classification of effects into formal frequency tiers establishes a neutral, fact-based summary of potential safety outcomes, focusing on the circumstances that governmental agencies link to elevated safety concerns.

Overdose and Emergency Response

The official overdose profile for Salticin (Gentamicin Sulfate) is strictly defined by severe toxicity to the renal and nervous systems, demanding immediate emergency action based on regulatory guidance.

Manifestation Type Documented Signs/Outcomes
Organ Toxicity Nephrotoxicity (evidenced by increased BUN/creatinine, reduced clearance), Ototoxicity (tinnitus, vertigo, irreversible hearing loss, balance problems).
Severe Neurological Neurotoxicity (confusion, convulsions/seizures), Neuromuscular Blockade (leading to life-threatening respiratory paralysis).

When to Seek Immediate Help: Governmental guidance explicitly states that urgent medical attention is required for life-threatening events. Call emergency services immediately if the individual experiences trouble breathing, convulsions, collapse, or cannot be awakened. Immediate medical evaluation is also required for severe systemic reactions, such as anaphylaxis.

Official Management and Monitoring: Regulatory documents mandate close monitoring of both renal function and the eighth cranial nerve function (hearing and balance) due to the risk of irreversible harm. Management procedures described in official labeling focus on drug removal, with hemodialysis documented as a way to aid clearance. No specific chemical antidote is known; however, intravenous administration of Calcium is the documented procedural intervention to reverse respiratory paralysis caused by neuromuscular blockade. Individuals with impaired renal function or advanced age are formally noted to have an increased risk of toxicity.

Therapeutic Uses of Salticin

What Salticin Treats: Main Uses and Benefits

Salticin (Gentamicin Sulfate) is commonly used for managing acute bacterial infections in situations where symptomatic management is appropriate, and is used to help address the bacterial source. The medication is applied in addressing serious bacterial conditions across various systems of the body.

The medication is generally used across conditions presenting with acute, disruptive episodes caused by susceptible bacteria. These include systemic infections such as sepsis and bacterial meningitis, as well as localized concerns like infected wounds, burns, impetigo, and acute bacterial eye infections such as conjunctivitis and keratitis. The key therapeutic benefit is the eradication of the bacteria to help manage the systemic burden or clear localized infection, supporting patient stability.

“It is commonly used when symptoms create noticeable physiological strain and management of the bacterial source is appropriate.”

The use of Salticin in these contexts helps address symptom clusters that may create noticeable functional strain, such as high fever in systemic cases, and swelling, pain, and discharge in localized skin and eye infections. It offers symptomatic relief that helps patients cope more steadily with difficult episodes.


Quick Fact: Therapeutic Use

  • Systemic Benefit: Relevant in contexts involving heightened systemic burden from serious bacterial infections.
  • Local Support: Applied in scenarios where additional management of discomfort is required for skin and eye infections.

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Eligibility and Population Restrictions

Eligibility for Salticin (Gentamicin Sulfate) is strictly defined by government regulatory agencies based on established safety profiles for specific patient groups and conditions. The eligibility status falls into three classifications: contraindicated, restricted, and allowed.

Classification Key Population or Condition
Absolute Contraindication History of hypersensitivity to Gentamicin, any other aminoglycoside antibiotic, or specific excipients (like sulfites) in the formulation.
Restricted Use Patients with impaired renal function, pre-existing auditory/vestibular damage, or neuromuscular disorders (e.g., Myasthenia Gravis).
Not Recommended Pregnancy (systemic use) due to documented risk of fetal ototoxicity (potential for irreversible congenital deafness). Lactation requires caution.

Age-Related Eligibility

Salticin is approved for use in adults, children, and neonates. However, use in neonates and geriatric patients requires close monitoring due to the higher likelihood of reduced or immature renal function, which can increase the risk of drug accumulation and toxicity, as stated in official labeling. Pre-existing electrolyte imbalances must also be corrected prior to use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Salticin (Gentamicin Sulfate) around the risk of additive toxicity and potential pharmacodynamic enhancement.

Contraindicated and High-Risk Combinations

Co-administration with other nephrotoxic (kidney-damaging) agents, such as Cisplatin or Vancomycin, is explicitly restricted due to a documented additive organ toxicity risk. The concurrent or sequential use of potent diuretics, including Furosemide or Ethacrynic Acid, is similarly restricted due to the increased risk of ototoxicity (ear damage). Use with neuromuscular blocking agents (e.g., muscle relaxants) is a high-risk combination, as Salticin possesses a curare-like effect that can enhance neuromuscular blockade.

Exposure and Procedural Constraints

Exposure modification is noted in certain populations: the risk of toxicity is increased in elderly patients and those with impaired renal function due to reduced clearance. Furthermore, specific conditions apply to administration: Salticin is physically incompatible with beta-lactam antibiotics like Penicillins and must not be mixed in the same solution for intravenous delivery; administration must be separate. No specific interactions with food, alcohol, or common herbal products are formally documented.

Mechanism of Action

Targeting the 30S Ribosome and Inhibiting Protein Synthesis

Salticin's mechanism begins with its specific high-affinity binding to the 30S ribosomal subunit of the bacterial cell. This direct interaction functions as an inhibitor that blocks the bacteria's ability to assemble new proteins required for cellular function and assembly.

The Bactericidal Cascade: Mistranslation and Cell Disruption

The drug's binding actively corrupts the protein-building process by inducing translational errors (mistranslation) in the messenger RNA. The resulting accumulation of faulty, non-functional proteins then severely compromises the integrity of the bacterial cell membrane, leading to rapid and irreversible damage and cell death (a bactericidal effect).

Mechanistic Constraints: Oxygen Dependency

A critical constraint is the drug's requirement for an oxygen-dependent active transport system to enter the bacterial cell and reach its ribosomal target. This results in reduced or absent drug action in anaerobic environments (e.g., deep abscesses) where oxygen is limited, despite the potential sensitivity of the ribosomal target.

Dosage and Administration Information

Salticin (Gentamicin Sulfate) is administered through distinct routes depending on the required use. The medication is used parenterally via Intramuscular (IM) injection or Intravenous (IV) infusion for systemic use, and locally as an Ophthalmic Solution or Ointment or Topical Ointment for surface applications. The systemic dose for adults is fundamentally calculated based on the patient’s body mass, specifically the estimated lean body mass, with a common total daily dose of 3 mg/kg.

This total systemic daily dose is administered in a divided fashion, typically as three equal portions given every eight hours. The duration of systemic use is generally set at 7 to 10 days, though longer courses may be necessary under close monitoring. For IV infusion, the solution must be appropriately diluted in a sterile fluid and administered slowly over 0.5 to 2 hours; the drug must not be physically premixed with other agents in the same container.

Localized administration follows a different schedule. The ophthalmic solution, available as a 0.3% concentration, is typically administered every four hours for mild to moderate conditions, increasing in frequency up to every hour for severe eye infections. Dosage adjustments are required for systemic use in patients with renal impairment, where the regimen is modified based on their measured kidney function.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Salticin

The research base for Salticin (Gentamicin Sulfate) includes various types of studies, primarily focusing on the medicine's clinical evaluation for addressing bacterial infections. The available evidence is reviewed by regulatory bodies as part of the process for defining its approved indications.

Evidence for use in Serious Systemic Infections

This section will summarize the design and focus of core clinical trials, systematic reviews, and meta-analyses that have examined the injectable form of Salticin for treating serious infections like sepsis and bacterial meningitis.

Research has primarily examined the use of Salticin in combination regimens with other antibiotics. Researchers monitored outcomes related to patient survival and overall mortality, as well as microbiological measures of examining the rate of microbiological eradication. Findings indicate that studies often reported measurements of patient survival when Salticin was included as part of an investigational regimen for severe infections.

What remains uncertain is the full role of Salticin when not used alongside other drugs; few data are available to determine its individual contribution to measured clinical or microbiological results. Furthermore, the follow-up durations were limited in many core trials, meaning long-term effects are not fully established.

Evidence for use in Localized and Surface Infections

This block outlines the research base, including randomized and comparative trials, that investigated the ophthalmic (eye drops/ointment) and topical forms of Salticin for acute bacterial eye infections and infected wounds.

Studies have focused on the ophthalmic solution and ointment for eye conditions linked to inflammatory or irritative states. Studies report measured changes in local symptoms over the treatment period, and findings describe patterns observed regarding the rate of microbiological clearance in specific types of skin infections. Evidence quality varies across studies regarding the use of Salticin in general topical skin applications. Data for certain groups remain insufficient regarding the use of the topical form for chronic, deep-seated skin conditions.

Key Studies & References

  1. Aminoglycosides: NLM Review (Used for class and systemic context)
  2. Gentamicin: MedlinePlus Drug Information (Used for general indications and context)
  3. Efficacy of topical gentamicin in chronic wound infections: Systematic Review (Supports evidence for localized use)

Frequently Asked Questions (FAQ)

Common questions about Salticin (FAQ)

Q: Does Salticin need to be taken at a specific time of day?

A: For systemic use, the total daily dose is typically administered in divided portions, such as every eight hours. Regulatory labeling indicates the importance of maintaining this consistent schedule for effective levels of the medicine in the body.

Q: Is Salticin safe to use long-term?

A: Official product information documents indicate that the risk of major toxicities, specifically damage to the kidneys (nephrotoxicity) and inner ear (ototoxicity), is officially documented as being increased by prolonged treatment duration. Therefore, systemic use is typically limited to a specific duration as defined in official guidelines.

Q: Can Salticin be used by children or teenagers?

A: Salticin is approved for use in adults, children, and neonates. Regulatory sources note that use in all pediatric age groups, including teenagers, requires careful monitoring due to the potential for reduced or immature kidney function.

Q: Can people with kidney problems use Salticin?

A: Use of Salticin in patients with impaired renal (kidney) function is restricted and considered a high-risk condition. Official documents require that the dosage regimen be modified and adjusted based strictly on the patient’s measured kidney function to reduce the risk of toxicity.

Q: What does the research evidence suggest about the long-term effectiveness of Salticin?

A: Official research evidence and labeling note that the follow-up periods in many core clinical trials were limited. Official documents state that definitive data on the long-term effects and effectiveness of the medicine are not fully established due to limited follow-up.

Q: Is Salticin generally well-tolerated?

A: While the medicine is widely used, official safety information emphasizes the potential for two principal adverse reactions: Nephrotoxicity (kidney damage), which is common, and Ototoxicity (inner ear damage), which is uncommon to rare.

Q: What is the availability of Salticin in different forms (e.g., tablet, liquid)?

A: Salticin is available as a sterile solution for injection (IV or IM), an ophthalmic solution (eye drops), an ophthalmic ointment, and a topical skin ointment. According to official labeling, it is not manufactured or supplied as an oral pill or tablet form.

Q: Is Salticin a controlled substance?

A: Official records and government classifications state that Gentamicin Sulfate (Salticin) is not listed as a controlled substance by the DEA (Drug Enforcement Administration) or equivalent international bodies.

Q: Can Salticin cause weight gain or weight loss?

A: Some official reports have noted weight loss as a possible side effect. Unexplained or significant weight gain or swelling has been noted as a symptom that requires clinical evaluation for potential kidney damage (nephrotoxicity), a documented risk associated with the drug.

Q: Does Salticin affect sleep patterns?

A: Direct changes to sleep patterns are not a commonly listed side effect in official documents. However, general side effects such as unusual tiredness, weakness, or mental changes have been noted in the safety profile.

Q: Are there any common foods or drinks that should be avoided when taking Salticin?

A: Regulatory documents state that no specific interactions with common foods or common herbal products are formally documented for Salticin.

Q: Is Salticin the same type of medicine as [similar common drug name]?

A: Salticin’s active component, Gentamicin Sulfate, is officially classified as a potent Aminoglycoside Antibiotic. This classification defines its fundamental type and its powerful bactericidal mechanism of action.

Q: What is the difference between Salticin and generic versions?

A: Salticin is the original brand name for the medicine. The generic versions contain the exact same active ingredient, Gentamicin Sulfate, at the same strength, and official regulatory agencies affirm they meet the same quality and efficacy standards as the brand product.

Q: Can Salticin be taken with routine supplements like vitamins?

A: Official product information advises that patients should inform their healthcare professional about all concomitant use of other products, including routine supplements, vitamins, minerals, and herbal products, to allow for a complete review of all concurrent products.

Q: Can Salticin be split or crushed if I have trouble swallowing pills?

A: Salticin is not manufactured as a pill or tablet that can be swallowed or modified. The systemic form is a sterile solution administered via injection or IV infusion.

Q: Is it normal to feel [general symptom, e.g., tired or dizzy] when starting Salticin?

A: Symptoms such as unusual tiredness or weakness are noted as possible side effects. The regulatory safety profile also lists dizziness or balance disturbance as a sign of potential ototoxicity (inner ear damage) which should be monitored closely.

Q: Does Salticin interact with common pain relievers like ibuprofen or acetaminophen?

A: Official drug interaction data lists high-risk combinations with certain classes of medicines, such as those that can also cause damage to the kidneys or ears. The decision regarding the use of all over-the-counter pain relievers requires discussion with a healthcare provider to identify any potential interaction risks.

Q: How long does Salticin stay in your system after stopping it?

A: Official pharmacokinetic data indicates that the medicine has a short half-life of approximately 65 minutes in adults with normal kidney function. It takes several half-lives for the drug to be fully cleared. Clearance is noted as being significantly slower in patients with impaired kidney function.

Q: What is the risk of dependence or withdrawal symptoms with Salticin?

A: Regulatory classification shows that Salticin is not a controlled substance. As an antibiotic, official safety information indicates it is not associated with the risk of dependence or withdrawal symptoms commonly seen with habit-forming medications.

Q: Are there any known interactions between Salticin and alcohol?

A: According to official regulatory documents, no specific interactions between Salticin and alcohol consumption are formally documented.

Q: Can Salticin impact fertility or reproductive health?

A: Animal studies reviewed by regulatory bodies did not find evidence of impaired fertility due to Gentamicin Sulfate. However, official documents state that information specific to human fertility or reproductive capacity is not definitively established.

Q: Does Salticin affect blood pressure or heart rate?

A: Official safety information indicates that changes in blood pressure (both high and low) and heart rate (fast heartbeat) have been reported as possible side effects or symptoms of a serious reaction. These changes have been noted as symptoms that may require clinical evaluation.

Q: Is a specific diet required while taking Salticin?

A: Official product labeling and regulatory documents do not mandate that patients must follow a specific diet while using Salticin.

Q: Why do official documents mention liver function tests for Salticin users?

A: The official safety profile focuses most heavily on kidney and ear damage. While severe liver disease may be a factor influencing dosing eligibility for certain treatment regimens, the primary required monitoring mentioned in official documents is for kidney function.

Q: Are there any restrictions on driving or operating machinery while taking Salticin?

A: Because side effects such as dizziness, imbalance, and blurred vision may occur, regulatory guidance notes that patients should be cautious about driving or operating machinery until they understand how the medicine affects them.

Q: Does Salticin interact with caffeine?

A: Official regulatory documents do not formally address a specific interaction between Salticin and caffeine consumption.

Q: Is Salticin considered a first-line treatment for its approved condition?

A: For serious systemic infections, official research and labeling often describe Salticin as being part of a combination regimen with other antibiotics. It may be used when other treatments are not suitable or effective for the specific bacterial strain.

Q: Does Salticin cause sun sensitivity or skin issues?

A: The official safety profile notes that skin reactions such as rash, itching, and hives have been reported as possible side effects. Sun sensitivity (photosensitivity) is not explicitly listed in the official documents.

Q: Can Salticin be taken on an empty stomach?

A: Since Salticin (Gentamicin Sulfate) is primarily administered via injection or as a topical application (eye drops/ointment), its use bypasses the digestive system and is not affected by whether or not a person has food in their stomach.

Q: Does Salticin affect the results of any common lab tests?

A: The drug's safety profile requires mandatory monitoring of kidney function (creatinine) and serum drug concentrations. Furthermore, official documentation states that pre-existing electrolyte imbalances should be corrected prior to its use.

Q: Can Salticin cause changes in mood or anxiety levels?

A: Official product information lists mood or mental changes, confusion, depression, and agitation as possible side effects that may occur during treatment.

Q: Is Salticin known to cause hair loss?

A: Hair loss has been noted in some official information as a possible side effect, especially when observed in pediatric patients.

Q: How are the side effects of Salticin managed according to medical sources?

A: Management for the most significant potential side effects, such as kidney or ear damage, involves the medical decision to reduce the dosage or discontinue the medicine. This action may often lead to the reversal of the adverse effect.

Q: What is the official recommendation regarding Salticin and breastfeeding?

A: Studies indicate the medicine is poorly excreted into breastmilk. Official recommendations suggest balancing the drug's importance to the mother with the potential risk to the infant, such as possible effects on gastrointestinal flora.

Q: Does Salticin have a delayed or immediate release formulation?

A: Salticin is primarily a liquid administered by injection or topical application. When administered systemically via IV infusion, it is managed over a period of time, typically 0.5 to 2 hours, to control the rate of release into the bloodstream.

Q: Can taking Salticin cause changes in vision?

A: Changes in vision, including blurred or double vision, as well as eye pain, have been reported in official product information as possible side effects.

Q: What are the ingredients in Salticin besides the active medicine?

A: Besides the active ingredient, Gentamicin Sulfate, the specific formulation (injection, ophthalmic, or topical) contains various inactive ingredients, also known as excipients. These include preservatives and stabilizers used to ensure product quality and stability.

Q: Is it common to need a higher dose of Salticin over time?

A: Official documentation suggests that instead of needing a higher dose due to tolerance, prolonged use may actually cause the medicine to accumulate in the body due to slower clearance, which can increase the risk of toxicity. Dosage adjustments are often made to account for slower clearance.

How should Salticin be stored and disposed of?

How to Store and Dispose of Salticin?

Salticin must be stored according to regulatory requirements to ensure its stability. Keep the product at controlled room temperature, which is between 20 C and 25 C. It is essential to protect the medication from light and moisture and store it in its original container, tightly closed. Do not freeze the product. After opening or dilution for injection, the product should be used immediately, with diluted solutions demonstrating stability for 24 hours at 25 C. Keep Salticin out of the sight and reach of children.

Dispose of any unused or expired Salticin strictly according to local regulations. The product must not be disposed of in household wastewater or drains.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Salticin found in:

A-Z Index: